Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon.
Abbas
N A
NA
Renal Unit, Royal Preston Hospital, Lancashire, UK.
Pitt
M A
MA
Green
A T
AT
Solomon
L R
LR
D000328:Adult; D002353:Carrier State; D003404:Creatinine / Q000097:blood; D015432:Glomerulonephritis, Membranoproliferative / Q000209:etiology* / Q000473:pathology / Q000628:therapy*; D006509:Hepatitis B / Q000150:complications; D006515:Hepatitis B virus / Q000472:pathogenicity*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008854:Microscopy, Electron; D009404:Nephrotic Syndrome / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011507:Proteinuria / Q000209:etiology / Q000628:therapy; D011994:Recombinant Proteins; D012709:Serum Albumin / Q000378:metabolism
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012709:Serum Albumin; D003404:Creatinine